Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3).

Full metadata record
DC Field Value Language
dc.contributor.authorGo, Se-Il-
dc.contributor.authorLee, Sang-Cheol-
dc.contributor.authorBae, Woo Kyun-
dc.contributor.authorZang, Dae Young-
dc.contributor.authorLee, Hyun Woo-
dc.contributor.authorJang, Joung Soon-
dc.contributor.authorJi, Jun Ho-
dc.contributor.authorKim, Jung Hoon-
dc.contributor.authorPark, Sanggon-
dc.contributor.authorSym, Sun Jin-
dc.contributor.authorYang, Yaewon-
dc.contributor.authorJeon, So Yeon-
dc.contributor.authorOh, Sung Yong-
dc.contributor.authorKang, Jung Hun-
dc.date.accessioned2022-01-26T02:43:25Z-
dc.date.available2022-01-26T02:43:25Z-
dc.date.issued2021-05-
dc.identifier.issn0732-183X-
dc.identifier.issn1527-7755-
dc.identifier.urihttps://scholarworks.bwise.kr/cau/handle/2019.sw.cau/54519-
dc.language영어-
dc.language.isoENG-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.titleModified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3).-
dc.typeArticle-
dc.identifier.doi10.1200/JCO.2021.39.15_suppl.4119-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15-
dc.description.isOpenAccessN-
dc.identifier.wosid000708120602219-
dc.citation.number15-
dc.citation.titleJOURNAL OF CLINICAL ONCOLOGY-
dc.citation.volume39-
dc.type.docTypeMeeting Abstract-
dc.publisher.location미국-
dc.relation.journalResearchAreaOncology-
dc.relation.journalWebOfScienceCategoryOncology-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > College of Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE